TLR8 agonist selgantolimod regulates Kupffer cell differentiation status and impairs HBV entry into hepatocytes via an IL-6-dependent mechanism
Source
Gut : the journal of the British Society for Gastroenterology - ISSN 0017-5749- (2024) p. 1-11